Free Trial
NASDAQ:MDXG

MiMedx Group (MDXG) Stock Price, News & Analysis

MiMedx Group logo
$7.17 +0.01 (+0.14%)
Closing price 08/27/2025 04:00 PM Eastern
Extended Trading
$7.17 0.00 (0.00%)
As of 08/27/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MiMedx Group Stock (NASDAQ:MDXG)

Key Stats

Today's Range
$7.10
$7.23
50-Day Range
$5.81
$7.31
52-Week Range
$5.47
$10.14
Volume
308,426 shs
Average Volume
797,743 shs
Market Capitalization
$1.06 billion
P/E Ratio
34.14
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

MiMedx Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

MDXG MarketRank™: 

MiMedx Group scored higher than 66% of companies evaluated by MarketBeat, and ranked 339th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MiMedx Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MiMedx Group has only been the subject of 1 research reports in the past 90 days.

  • Read more about MiMedx Group's stock forecast and price target.
  • Earnings Growth

    Earnings for MiMedx Group are expected to grow by 6.67% in the coming year, from $0.30 to $0.32 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MiMedx Group is 34.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.62.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MiMedx Group is 34.14, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.86.

  • Price to Book Value per Share Ratio

    MiMedx Group has a P/B Ratio of 4.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MiMedx Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.44% of the float of MiMedx Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiMedx Group has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in MiMedx Group has recently decreased by 9.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MiMedx Group does not currently pay a dividend.

  • Dividend Growth

    MiMedx Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.44% of the float of MiMedx Group has been sold short.
  • Short Interest Ratio / Days to Cover

    MiMedx Group has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in MiMedx Group has recently decreased by 9.42%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MiMedx Group has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for MiMedx Group this week, compared to 4 articles on an average week.
  • Search Interest

    Only 2 people have searched for MDXG on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added MiMedx Group to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MiMedx Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.70% of the stock of MiMedx Group is held by insiders.

  • Percentage Held by Institutions

    79.15% of the stock of MiMedx Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MiMedx Group's insider trading history.
Receive MDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDXG Stock News Headlines

MIMEDX to Participate in Upcoming Investor Conferences
Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
MiMedx Group Inc. Reports Record Earnings and Growth
MiMedx Group (MDXG) Receives a Buy from Northland Securities
See More Headlines

MDXG Stock Analysis - Frequently Asked Questions

MiMedx Group's stock was trading at $9.62 at the beginning of 2025. Since then, MDXG stock has decreased by 25.5% and is now trading at $7.17.

MiMedx Group, Inc (NASDAQ:MDXG) posted its quarterly earnings results on Wednesday, July, 30th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.06 by $0.04. The company earned $98.61 million during the quarter, compared to analyst estimates of $90.79 million. MiMedx Group had a trailing twelve-month return on equity of 23.03% and a net margin of 8.84%.
Read the conference call transcript
.

MiMedx Group's top institutional investors include Trigran Investments Inc. (5.67%), Paradigm Capital Management Inc. NY (3.01%), Geode Capital Management LLC (1.92%) and Cannell Capital LLC (1.40%). Insiders that own company stock include Joseph H Capper, William Frank Iv Hulse, Ricci S Whitlow, Robert Benjamin Stein, Kimberly Maersk-Moller, William Lawrence Phelan and Rice Doug.
View institutional ownership trends
.

Shares of MDXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MiMedx Group investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Hawkins (HWKN), Adobe (ADBE) and GE Aerospace (GE).

Company Calendar

Last Earnings
7/30/2025
Today
8/28/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MDXG
CIK
1376339
Employees
870
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$12.00
Potential Upside/Downside
+67.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.21
Trailing P/E Ratio
34.14
Forward P/E Ratio
23.90
P/E Growth
N/A
Net Income
$42.42 million
Net Margins
8.84%
Pretax Margin
12.18%
Return on Equity
23.03%
Return on Assets
17.09%

Debt

Debt-to-Equity Ratio
0.08
Current Ratio
4.39
Quick Ratio
3.90

Sales & Book Value

Annual Sales
$348.88 million
Price / Sales
3.04
Cash Flow
$0.33 per share
Price / Cash Flow
21.61
Book Value
$1.46 per share
Price / Book
4.91

Miscellaneous

Outstanding Shares
147,960,000
Free Float
145,444,000
Market Cap
$1.06 billion
Optionable
Optionable
Beta
1.79

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:MDXG) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners